• News

"New Study on ‘Breakthrough’ Atopic Dermatitis Drug Indicates ‘Eczema Is An Autoimmune Disease’"

  • Inquisitr
  • (February 26, 2015)

Researchers behind a new study on the atopic dermatitis drug “dupilumab” (which is currently in trials) say that they have proven that this form of eczema is an autoimmune disease. The potential atopic dermatitis medication blocks the activity of two key immune proteins, interleukin-4 (IL-4) and interleukin-13 (IL-13), and according to the researchers, can reverse the immune response within an allergic individual that causes the atopic dermatitis skin problems. The promising new atopic dermatitis drug study was led by Emma Guttman-Yassky, MD, Associate Professor of Dermatology at the Icahn School of Medicine at Mount Sinai. Learn more.

Related Articles
Icahn
Pelvic Stock Image
Software Tool Aims to Help Scientists Better Analyze Complex Spatial Data From Tissues
Building exterior
Building exterior
REsearcher using computer
Image of researcher
Elahi
Doctor adjusting microscope
Team
Building exterior